NDC 50474-970 – Briviact
Brivaracetam 50 mg/5mL · Injection, Suspension · Intravenous
Product NDC50474-970
Product details
Active ingredients
- Brivaracetam 50 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50474-970-75 | 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63) | May 12, 2016 |
Recalls mentioning this NDC
- D-0591-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Briviact products
- 50474-370 Brivaracetam 10 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-470 Brivaracetam 25 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-570 Brivaracetam 50 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-670 Brivaracetam 75 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-770 Brivaracetam 100 mg/1 · Tablet, Film Coated · UCB, Inc.
- 50474-870 Brivaracetam 10 mg/mL · Solution · UCB, Inc.